Loss of p53 enhances NF-κB-dependent lamellipodia formation

J Cell Physiol. 2014 Jun;229(6):696-704. doi: 10.1002/jcp.24505.

Abstract

Tumor suppressor p53 prevents tumorigenesis and tumor growth by suppressing the activation of several transcription factors, including nuclear factor-κB (NF-κB) and STAT3. On the other hand, p53 stimulates actin cytoskeleton remodeling and integrin-related signaling cascades. Here, we examined the p53-mediated link between regulation of the actin cytoskeleton and activation of NF-κB and STAT3 in MCF-7 cells and mouse embryonic fibroblasts (MEFs). In the absence of p53, STAT3 was constitutively activated. This activation was attenuated by depleting the expression of p65, a component of NF-κB. Integrin β3 expression and lamellipodia formation were also downregulated by NF-κB depletion. Inhibition of integrin αvβ3, Rac1 or Arp2/3, which diminished lamellipodia formation, suppressed STAT3 activation induced by p53 depletion. These results suggest that loss of p53 leads to STAT3 activation via NF-κB-dependent lamellipodia formation. Our study proposes a novel role for p53 in modulating the actin cytoskeleton through suppression of NF-κB, which restricts STAT3 activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Animals
  • Cells, Cultured
  • Fibroblasts / metabolism
  • Gene Expression Regulation / physiology
  • Humans
  • I-kappa B Kinase / genetics
  • I-kappa B Kinase / metabolism
  • Integrin beta3 / genetics
  • Integrin beta3 / metabolism
  • MCF-7 Cells
  • Mice
  • NF-kappa B / metabolism*
  • Pseudopodia / drug effects*
  • Pseudopodia / physiology
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Integrin beta3
  • NF-kappa B
  • STAT3 Transcription Factor
  • Tumor Suppressor Protein p53
  • I-kappa B Kinase